199 related articles for article (PubMed ID: 12646118)
1. [Anterior uveitis in a patient treated with pegylated interferon and ribavirin].
Carneros Martín JA; Fuentes Coronel A; Alvarez Delgado A; González San Martín F
Med Clin (Barc); 2003 Mar; 120(9):359. PubMed ID: 12646118
[No Abstract] [Full Text] [Related]
2. [A doubtful case of anterior uveitis drug related].
Palop Larrea V; Morales Olivas JM; Martínez-Mir I
Med Clin (Barc); 2003 Nov; 121(16):636-7; author reply 637. PubMed ID: 14636544
[No Abstract] [Full Text] [Related]
3. Leukocytoclastic vasculitis during pegylated interferon and ribavirin treatment of hepatitis C virus infection.
Adişen E; Dizbay M; Hizel K; Ilter N
Indian J Dermatol Venereol Leprol; 2008; 74(1):60-2. PubMed ID: 18187830
[No Abstract] [Full Text] [Related]
4. Pegylated interferon/ribavirin-induced sudden sensorineural hearing loss in a patient with chronic hepatitis C.
Atug O; Akin H; Yilmaz Y; Sari M; Tozun N
J Gastrointestin Liver Dis; 2009 Jun; 18(2):256. PubMed ID: 19565068
[No Abstract] [Full Text] [Related]
5. Expectoration of large bronchial casts secondary to the treatment of chronic hepatitis C with pegylated interferon and ribavirin.
Araújo ES; Campos AF; Yamashiro J; Mello ES; Takagaki T; Barone AA
Clinics (Sao Paulo); 2010 Jul; 65(7):745-8. PubMed ID: 20668635
[No Abstract] [Full Text] [Related]
6. Retinal thrombosis secondary to the combination therapy of pegylated interferon and ribavirin for chronic hepatitis C virus infection. A rare complication.
Ortega-Ibarra FS; Remes-Troche JM
Rev Esp Enferm Dig; 2013; 105(5):291-2. PubMed ID: 23971660
[No Abstract] [Full Text] [Related]
7. [A case of vasculitis in chronic hepatitis C patient treated with pegylated interferon alpha-2a and ribavirin].
Kim YH; Han WS; Lee SJ; Oh SN; Choi DW; Byun KS; Yeon JE
Korean J Hepatol; 2007 Sep; 13(3):419-22. PubMed ID: 17898559
[TBL] [Abstract][Full Text] [Related]
8. Nephrotic syndrome with pegylated interferon alfa 2a and ribavirin for a patient with chronic hepatitis C.
Sood A; Midha V; Sandhu JS; Sood N; Kaur A; Mittal R; Puri S
Indian J Gastroenterol; 2010 Jun; 29(3):124-5. PubMed ID: 20803821
[No Abstract] [Full Text] [Related]
9. Iatrogenic hyperpigmentation in chronically infected hepatitis C patients treated with pegylated interferon and ribavirin.
Lin J; Lott JP; Amorosa VK; Kovarik CL
J Am Acad Dermatol; 2009 May; 60(5):882-3. PubMed ID: 19389538
[No Abstract] [Full Text] [Related]
10. Acute ulcerative colitis during successful interferon/ribavirin treatment for chronic hepatitis.
Sprenger R; Sagmeister M; Offner F
Gut; 2005 Mar; 54(3):438-9; author reply 439. PubMed ID: 15710996
[No Abstract] [Full Text] [Related]
11. Pegylated interferon alpha-2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients.
Callens S; Bottieau E; Michielsen P; Colebunders R
AIDS; 2004 Jan; 18(1):131. PubMed ID: 15090841
[No Abstract] [Full Text] [Related]
12. Nonischemic cardiomyopathy related to pegylated interferon and ribavirin.
Choy-Shan A; Berezovskaya S; Zinn A; Sedlis SP; Bini EJ
Eur J Gastroenterol Hepatol; 2009 Dec; 21(12):1438-40. PubMed ID: 19907230
[No Abstract] [Full Text] [Related]
13. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
Rogers CJ; Romagosa R; Vincek V
J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524
[No Abstract] [Full Text] [Related]
14. [Acute portal thrombosis in patients with hepatitis C treated with pegylated interferon and ribavirin].
Merino Rodríguez B; Díaz Sánchez A; Matilla Peña A; Clemente Ricote G; Núñez Martínez O
Gastroenterol Hepatol; 2008 Jan; 31(1):18-21. PubMed ID: 18218275
[TBL] [Abstract][Full Text] [Related]
15. Unilateral hearing loss due to pegylated interferon-α2b and ribavirin therapy.
Jain S; Midha V; Sood A
Indian J Gastroenterol; 2011 Sep; 30(5):239-40. PubMed ID: 21986854
[No Abstract] [Full Text] [Related]
16. Vitiligo after combination therapy of pegylated interferon-α-2a, ribavirin and vitamin D in a patient with chronic hepatitis C.
Oiso N; Sato M; Kawada A
J Dermatol; 2013 Sep; 40(9):772-3. PubMed ID: 23855823
[No Abstract] [Full Text] [Related]
17. Fatal cardiomyopathy associated with pegylated interferon/ribavirin in a patient with chronic hepatitis C.
Condat B; Asselah T; Zanditenas D; Estampes B; Cohen A; O'Toole D; Bonnet J; Ngo Y; Marcellin P; Blazquez M
Eur J Gastroenterol Hepatol; 2006 Mar; 18(3):287-9. PubMed ID: 16462543
[TBL] [Abstract][Full Text] [Related]
18. Side effects of therapy for chronic hepatitis C.
Russo MW; Fried MW
Gastroenterology; 2003 May; 124(6):1711-9. PubMed ID: 12761728
[No Abstract] [Full Text] [Related]
19. [Generalized eczema secondary to combined treatment with peginterferon alfa-2a and ribavirin in a patient with chronic hepatitis from the hepatitis C virus].
Ruiz de Casas A; García-Bravo B; Camacho F
Actas Dermosifiliogr; 2005 Mar; 96(2):122-3. PubMed ID: 16476350
[TBL] [Abstract][Full Text] [Related]
20. Combination pegylated interferon and ribavirin therapy precipitating acute renal failure and exacerbating IgA nephropathy.
Gordon A; Menahem S; Mitchell J; Jenkins P; Dowling J; Roberts SK
Nephrol Dial Transplant; 2004 Aug; 19(8):2155. PubMed ID: 15252182
[No Abstract] [Full Text] [Related]
[Next] [New Search]
